Previous close | 0.6150 |
Open | 0.6050 |
Bid | 0.6100 x N/A |
Ask | 0.6450 x N/A |
Day's range | 0.6050 - 0.6050 |
52-week range | 0.5900 - 37.8000 |
Volume | |
Avg. volume | 88 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 15 Nov 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced that its nutraceuticals brand subsidiary, Biodroga Nutraceuticals Inc. ("Biodroga"), has entered into an accounts receivable factoring facility and inventory finance rider (collectively, the "Facility") with Alterna Capital Solutions, LLC ("Alterna"). The amount available under the Facility at any g
Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced it has entered into a non-binding Letter of Intent ("LOI") to acquire Datasys Group, Inc., ("Datasys") and affiliated companies. The non-binding LOI establishes the framework for a potential transaction (the "Proposed Transaction") whereby Neptune would acquire all the outstanding equity of Datasys,
Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced its financial and operating results for the three-month period ending September 30, 2023.